Literature DB >> 9679854

IgE-mediated allergy and desensitization to factor IX in hemophilia B.

A F Dioun1, B M Ewenstein, R S Geha, L C Schneider.   

Abstract

BACKGROUND: We describe two patients with factor IX deficiency and high levels of inhibitors to factor IX who developed anaphylaxis to factor IX.
OBJECTIVE: The aim of this study was to develop a skin test, RAST, and desensitization protocol for factor IX allergy.
METHODS: The patients were evaluated by skin test and RAST to factor IX. They also underwent desensitization to factor IX.
RESULTS: Both patients had positive skin test and RAST reactions to factor IX. Control subjects had negative reactions. Both patients were successfully desensitized to factor IX by using two different desensitization protocols. The patients' skin test and RAST reactions to factor IX converted to negative after desensitization.
CONCLUSIONS: IgE-mediated reactions to factor IX do occur and may be diagnosed with the use of skin test and RAST. Patients with this type of reaction may be successfully desensitized to factor IX.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679854     DOI: 10.1016/s0091-6749(98)70061-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice.

Authors:  Dheeraj Verma; Babak Moghimi; Paul A LoDuca; Harminder D Singh; Brad E Hoffman; Roland W Herzog; Henry Daniell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

2.  Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

Authors:  Margherita Mauro; Elisa Bonetti; Rita Balter; Giovanni Poli; Simone Cesaro
Journal:  Blood Transfus       Date:  2016-04-28       Impact factor: 3.443

Review 3.  Management of multiple drug allergies in children.

Authors:  Anahita Falakshahi Dioun
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

Review 4.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

5.  Successful Desensitization Protocol in an Infant Following Anaphylaxis Secondary to Recombinant Factor VIIa.

Authors:  Ezgi Ulusoy Severcan; Nursen Cigerci Gunaydin; Hamiyet Hekimci Ozdemir; Figen Gulen; Kaan Kavakli; Remziye Tanac; Esen Demir
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-09       Impact factor: 0.885

6.  Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.

Authors:  B Boylan; A S Rice; A T Neff; M J Manco-Johnson; C L Kempton; C H Miller
Journal:  J Thromb Haemost       Date:  2016-09-17       Impact factor: 5.824

Review 7.  Desensitization and immune tolerance induction in children with severe factor IX deficiency; inhibitors and adverse reactions to replacement therapy: a case-report and literature review.

Authors:  Andrea Bon; Massimo Morfini; Alessandro Dini; Francesca Mori; Simona Barni; Sottilotta Gianluca; Maurizio de Martino; Elio Novembre
Journal:  Ital J Pediatr       Date:  2015-02-19       Impact factor: 2.638

Review 8.  International consensus recommendations on the management of people with haemophilia B.

Authors:  Daniel P Hart; Davide Matino; Jan Astermark; Gerard Dolan; Roseline d'Oiron; Cédric Hermans; Victor Jiménez-Yuste; Adriana Linares; Tadashi Matsushita; Simon McRae; Margareth C Ozelo; Sean Platton; Darrel Stafford; Robert F Sidonio; Andreas Tiede
Journal:  Ther Adv Hematol       Date:  2022-04-02

Review 9.  Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment.

Authors:  Fumiya Hirayama
Journal:  Br J Haematol       Date:  2012-12-06       Impact factor: 6.998

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.